Adjunct Clinical Associate Professor of Internal Medicine
Service Chief
[email protected]
Available to mentor
Vivek Nagaraja
Adjunct Clinical Associate Professor
-
Zamora AC, Wesselius LJ, Gotway MB, Tazelaar HD, Diaz-Arumir A, Nagaraja V. Semin Respir Crit Care Med, 2024 Jun; 45 (3): 287 - 304.Journal ArticleDiagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases.
DOI:10.1055/s-0044-1785674 PMID: 38631369 -
Aragon Sierra AM, Hwang AS, Kechter J, Mangold AR, Nagaraja V, DiCaudo DJ. JAAD Case Rep, 2024 May; 47: 32 - 34.Journal ArticleSystemic sclerosis with morphea-like plaques histopathologically mimicking cutaneous B-cell lymphoma.
DOI:10.1016/j.jdcr.2024.02.028 PMID: 38576903 -
Nagaraja V, Mira-Avendano I, Diaz-Arumir A, Gotway M, Zamora AC. Revista Colombiana de Reumatologia, 2024 Apr 1; 31: S139 - S153.Journal ArticleInterstitial lung disease in autoimmune diseases
DOI:10.1016/j.rcreu.2023.12.004 -
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun J-B, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP, RESOLVE-1 Study Group . Arthritis Rheumatol, 2023 Sep; 75 (9): 1608 - 1618.Journal ArticleEfficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis.
DOI:10.1002/art.42510 PMID: 37098795 -
Ramahi A, Lescoat A, Roofeh D, Nagaraja V, Namas R, Huang S, Varga J, O'Dwyer D, Wang B, Flaherty K, Kazerooni E, Khanna D. Rheumatology (Oxford), 2023 Jul 5; 62 (7): 2501 - 2509.Journal ArticleRisk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.
DOI:10.1093/rheumatology/keac639 PMID: 36377780 -
Roofeh D, Brown KK, Kazerooni EA, Tashkin D, Assassi S, Martinez F, Wells AU, Raghu G, Denton CP, Chung L, Hoffmann-Vold A-M, Distler O, Johannson KA, Allanore Y, Matteson EL, Kawano-Dourado L, Pauling JD, Seibold JR, Volkmann ER, Walsh SLF, Oddis CV, White ES, Barratt SL, Bernstein EJ, Domsic RT, Dellaripa PF, Conway R, Rosas I, Bhatt N, Hsu V, Ingegnoli F, Kahaleh B, Garcha P, Gupta N, Khanna S, Korsten P, Lin C, Mathai SC, Strand V, Doyle TJ, Steen V, Zoz DF, Ovalles-Bonilla J, Rodriguez-Pinto I, Shenoy PD, Lewandoski A, Belloli E, Lescoat A, Nagaraja V, Ye W, Huang S, Maher T, Khanna D. Rheumatology (Oxford), 2023 May 2; 62 (5): 1877 - 1886.Journal ArticleSystemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
DOI:10.1093/rheumatology/keac557 PMID: 36173318 -
Wang B, Nagaraja V. Open Respir Med J, 2023 17: e187430642306150Journal ArticleDiagnosis and Management of Patients with Connective Tissue Disease-related Fibrosing Interstitial Lung Diseases.
DOI:10.2174/18743064-v17-e230714-2022-26 PMID: 37916138 -
Weiner JK, Smith T, Hoy CK, Sarosh C, Madison JA, Ambati A, Tambralli A, Peters N, Packel C, Gockman K, Zuo Y, Briceño EM, Nagaraja V, Knight JS. ACR Open Rheumatol, 2023 Jan; 5 (1): 28 - 37.Journal ArticlePredictors and Interrelationship of Patient-Reported Outcomes in Antiphospholipid Syndrome: A Cross-Sectional Study.
DOI:10.1002/acr2.11512 PMID: 36461647
